Japan’s Consumer Affairs Agency ordered Kirin Beverage to prevent a recurrence of deceptive packaging for its juice product.
Although its Tropicana melon taste juice product was labeled as 100 percent melon by Kirin Holdings, it contained only 2 percent melon juice and the remaining 98 percent was grape, apple, and banana juice.
According to the agency, the company used the disputed package between June 2020 and April this year, which stated "100% melon taste" and "selected muskmelon."
The agency said this amounts to a violation of the law against misleading representations.
Kirin Beverage is currently selling the product after changing its labeling.
“We deeply apologize for the misleading labeling causing misunderstanding among customers,” the company said.


Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
US Judge Rejects $2.36B Penalty Bid Against Google in Privacy Data Case
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Minnesota Judge Rejects Bid to Halt Trump Immigration Enforcement in Minneapolis
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
Why financial hardship is more likely if you’re disabled or sick
Trump Lawsuit Against JPMorgan Signals Rising Tensions Between Wall Street and the White House
Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Citigroup Faces Lawsuit Over Alleged Sexual Harassment by Top Wealth Executive 



